Eyenovia Inc

General ticker "EYEN" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $6.4M

Eyenovia Inc does not follow the US Stock Market performance with the rate: -32.3%.

Estimated limits based on current volatility of 1.7%: low 0.08$, high 0.09$

Factors to consider:

  • Current price 92.1% below estimated low
  • Earnings for 6 months up through Q2 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.07$, 2.81$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.28$, 3.15$]

Financial Metrics affecting the EYEN estimates:

  • Negative: Non-GAAP EPS, $ of -0.67 <= 0.10
  • Negative: Operating profit margin, % of -99.99 <= 1.03
  • Negative: Operating cash flow per share per price, % of -26.36 <= 2.35
  • Positive: Interest expense per share, $ of 0.06 <= 0.14
  • Negative: Industry earnings per price (median), % of -15.01 <= 1.31
  • Negative: negative Net income

Similar symbols

Short-term EYEN quotes

Long-term EYEN plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $14.00MM $0.00MM $0.00MM
Operating Expenses $27.02MM $26.91MM $25.41MM
Operating Income $-13.02MM $-26.91MM $-25.41MM
Non-Operating Income $0.24MM $-1.10MM $-1.85MM
Interest Expense $0.39MM $1.38MM $2.37MM
R&D Expense $14.51MM $13.38MM $12.98MM
Income(Loss) $-12.78MM $-28.01MM $-27.26MM
Profit(Loss) $-12.78MM $-28.01MM $-27.26MM
Stockholders Equity $20.47MM $17.23MM $9.00MM
Inventory $0.00MM $3.57MM $0.11MM
Assets $31.66MM $31.04MM $28.78MM
Operating Cash Flow $-20.87MM $-25.11MM $-23.84MM
Capital expenditure $1.62MM $0.87MM $3.97MM
Investing Cash Flow $-1.62MM $-0.87MM $-3.97MM
Financing Cash Flow $21.46MM $21.51MM $19.79MM
Earnings Per Share* $-0.49 $-0.82 $-0.66

* EPS are Split Adjusted, recent splits may be reflected with a delay.